TOKYO, January 31, 2025--Daiichi Sankyo Company, Ltd (TSE: 4568) has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, Ph.D. as Chief Executive Officer (CEO), effective April 1 ...
The Japanese market is trading sharply higher on Thursday, extending the gains in the previous three sessions, following the mixed ...
The Japanese stock market is modestly higher in post-holiday trading on Wednesday, adding to the gains in the previous two sessions, ...
Delhi: IHH Healthcare, a prominent global healthcare provider, has escalated its legal battle with Japan's Daiichi Sankyo, ...
Daiichi Sankyo has made a little bit of pharma industry ... and was discovered by scientists led by Prof Tomoki Todo of the University of Tokyo. During treatment, the oncolytic virus is injected ...
It was discovered by scientists led by Prof Tomoki Todo of the University of Tokyo. There are around 2,800 new cases of malignant glioma reported every year in Japan, according to Daiichi Sankyo ...
Daiichi Sankyo had opposed the open offer made in 2018 after Northern TK Venture had acquired a 31% stake in Fortis. NTK had then filed a lawsuit against Daiichi Sankyo in November 2023.
Healthcare Asia Magazine on MSN5d
IHH seeks up to $1.7b in compensation from JP’s Daiichi Sankyo over Fortis dealNorthern TK Venture filed a claim against Daiichi Sankyo saying the latter prevented NTK from proceeding with its open offer.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results